Thus, in this study, we examined infiltrations of CD4+, CD8+, and FOXP3+ TILs and PD-L1+ immune cells in DCIS in relation to clinicopathologic features and compared them with those of invasive breast cancer to evaluate their changes during progression of DCIS. This evidence concerns the gene FOXP3 and ductal breast carcinoma in situ.